Hansa Biopharma AB (publ) (STO:HNSA)

Hansa Biopharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	252.07	405.28	732.06	1,496	651.34	1,139
Short-Term Investments	-	-	-	-	237.62	238.14
Cash & Short-Term Investments	252.07	405.28	732.06	1,496	888.96	1,378
Cash Growth	-54.46%	-44.64%	-51.07%	68.31%	-35.47%	129.17%
Accounts Receivable	165.79	144.97	78.03	42.96	9.71	0.11
Other Receivables	42.74	17.49	15.73	24.22	13.53	7.59
Receivables	208.54	162.46	93.76	67.18	23.24	7.7
Inventory	3.53	2.61	1.51	0.97	0.24	0.1
Prepaid Expenses	-	2.84	3.06	3.52	3.34	1.66
Other Current Assets	-	12.24	24.76	36.85	26.56	6.43
Total Current Assets	464.14	585.43	855.15	1,605	942.34	1,393
Property, Plant & Equipment	11.53	17.88	27.07	35.84	41.71	9.7
Other Intangible Assets	265.44	20.46	23.17	26.01	28.76	31.41
Long-Term Deferred Charges	-	176.88	112.65	20.85	-	-
Total Assets	741.11	800.64	1,018	1,687	1,013	1,434
Accounts Payable	63.6	37.62	86.97	62.48	53.36	26.67
Accrued Expenses	126.76	97.89	116.54	100.32	78.22	52.36
Current Portion of Leases	8.15	7.68	7.5	7.17	6.89	4.42
Current Income Taxes Payable	1.95	2.71	1.6	0.6	-	0.13
Current Unearned Revenue	13.99	16.33	41.47	40.43	24.96	17.41
Other Current Liabilities	65.15	93.45	66.91	53.71	7.79	13.22
Total Current Liabilities	419.68	255.69	320.99	264.71	171.22	114.2
Long-Term Debt	774.7	1,065	844.9	762.6	-	-
Long-Term Leases	0.97	6.68	14.36	21.33	28.49	0.63
Long-Term Unearned Revenue	-	-	-	29.5	47.02	62.03
Long-Term Deferred Tax Liabilities	0.12	0.17	0.37	0.41	0.43	0.42
Other Long-Term Liabilities	106.38	63.3	5.3	5.95	8.08	15.09
Total Liabilities	1,302	1,390	1,186	1,084	255.24	192.37
Common Stock	-560.74	67.81	55.03	55.03	46.34	45.9
Additional Paid-In Capital	-	3,451	3,083	3,022	2,573	2,509
Retained Earnings	-	-4,110	-3,303	-2,471	-1,860	-1,312
Treasury Stock	-	-	-2.36	-2.59	-1.86	-1.42
Comprehensive Income & Other	-	0.94	-0.41	0.01	0.13	-0.14
Shareholders' Equity	-560.74	-589.83	-167.88	602.91	757.57	1,242
Total Liabilities & Equity	741.11	800.64	1,018	1,687	1,013	1,434
Total Debt	923.9	1,079	866.77	791.09	35.38	5.05
Net Cash (Debt)	-671.82	-673.73	-134.71	705.09	853.58	1,372
Net Cash Growth	-	-	-	-17.40%	-37.81%	131.98%
Net Cash Per Share	-9.24	-10.72	-2.56	15.70	19.19	32.54
Filing Date Shares Outstanding	84.72	67.81	52.67	52.44	44.47	44.47
Total Common Shares Outstanding	84.72	67.81	52.67	52.44	44.47	44.47
Working Capital	44.46	329.74	534.16	1,340	771.12	1,279
Book Value Per Share	-6.62	-8.70	-3.19	11.50	17.03	27.93
Tangible Book Value	-826.18	-610.29	-191.05	576.9	728.81	1,211
Tangible Book Value Per Share	-9.75	-9.00	-3.63	11.00	16.39	27.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.